Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Vomiting | Research article

Norovirus strain types found within the second infectious intestinal diseases (IID2) study an analysis of norovirus circulating in the community

Authors: John P. Harris, Miren Iturriza-Gomara, David J. Allen, Susan Kelly, Sarah J. O’Brien

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Norovirus is the commonest cause of infectious intestinal disease (IID) worldwide. In the UK community incidence of norovirus has been estimated at 59/1000 population, equating to four million cases a year. Whilst norovirus infects people of all ages, a substantial burden occurs in infants and young children. The population of viruses found in sporadic cases among infants has been observed to be more diverse than that associated with outbreaks. In this study, we analysed norovirus-positive specimens collected during the second study of infectious intestinal diseases (IID2 Study) a national community cohort study conducted between April 2008 and August 2009 We examined the data for differences in circulating norovirus strains between two arms of a community cohort, and differences between genotypes and disease outcomes such as illness duration and symptom profiles.

Methods

Analysis was conducted to assess genetic diversity of noroviruses in the community. We also assessed differences in the cycle threshold (Ct) value, as a proxy for viral load, between norovirus genogroups and genotypes, and differences in reported symptoms or length of illness in relation to genogroup and genotype.

Results

There were 477 samples where norovirus was detected. Whilst 85% of people recovered within two days for vomiting; diarrhoea symptoms were reported to day 4 for 83% of the cases, and 10% of people reported symptoms of diarrhoea lasting between five and six days. Both diarrhoea and vomiting symptoms lasted longer in children aged < 5 years compared to adults. There was a significantly higher proportion of GII.4 in samples obtained from the GP arm of the study (chi-square = 17.8, p < 0.001) compared to samples received via post in the self-reporting arm. In the latter group, the prevalence of GII.6 was significantly higher (chi-square = 7.5, p < 0.001).

Conclusions

We found that there is a difference in disease severity by age group. Children aged < 5 years had longer duration of illness, with 10% still having diarrhoea at seven days, and vomiting of between four and five days. The duration of illness reported is higher overall than one might expect for cases in the community in otherwise healthy individuals which has implications for infection control. No differences were observed in relation to duration of vomiting and or diarrhoea by genotype.
Literature
1.
go back to reference Belliot G, et al. The burden of norovirus gastroenteritis: an important foodborne and healthcare-related infection. Clin Microbiol Infect. 2014;20(8):724–30.CrossRef Belliot G, et al. The burden of norovirus gastroenteritis: an important foodborne and healthcare-related infection. Clin Microbiol Infect. 2014;20(8):724–30.CrossRef
2.
go back to reference Kroneman A, et al. Proposal for a unified norovirus nomenclature and genotyping. Arch Virol. 2013;158(10):2059–68.CrossRef Kroneman A, et al. Proposal for a unified norovirus nomenclature and genotyping. Arch Virol. 2013;158(10):2059–68.CrossRef
3.
go back to reference Vinje J. Advances in laboratory methods for detection and typing of norovirus. J Clin Microbiol. 2015;53(2):373–81.CrossRef Vinje J. Advances in laboratory methods for detection and typing of norovirus. J Clin Microbiol. 2015;53(2):373–81.CrossRef
4.
go back to reference Zakikhany K, et al. Molecular evolution of GII-4 norovirus strains. PLoS One. 2012;7(7):e41625.CrossRef Zakikhany K, et al. Molecular evolution of GII-4 norovirus strains. PLoS One. 2012;7(7):e41625.CrossRef
5.
go back to reference Vega E, et al. Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013. J Clin Microbiol. 2014;52(1):147–55.CrossRef Vega E, et al. Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013. J Clin Microbiol. 2014;52(1):147–55.CrossRef
6.
go back to reference Mans, J., et al., Norovirus diversity in children with gastroenteritis in South Africa from 2009 to 2013: GII.4 variants and recombinant strains predominate. Epidemiol Infect, 2015: p. 1–10. Mans, J., et al., Norovirus diversity in children with gastroenteritis in South Africa from 2009 to 2013: GII.4 variants and recombinant strains predominate. Epidemiol Infect, 2015: p. 1–10.
7.
go back to reference van Beek J, et al. Comparison of norovirus genogroup I, II and IV seroprevalence among children in the Netherlands, 1963, 1983 and 2006. J Gen Virol. 2016;97(9):2255–64.CrossRef van Beek J, et al. Comparison of norovirus genogroup I, II and IV seroprevalence among children in the Netherlands, 1963, 1983 and 2006. J Gen Virol. 2016;97(9):2255–64.CrossRef
8.
go back to reference Siebenga JJ, et al. Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J. Virol. 2007;81(18):9932–41.CrossRef Siebenga JJ, et al. Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J. Virol. 2007;81(18):9932–41.CrossRef
9.
go back to reference Lindesmith LC, et al. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med. 2008;5(2):e31.CrossRef Lindesmith LC, et al. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med. 2008;5(2):e31.CrossRef
10.
go back to reference Allen DJ, et al. Analysis of amino acid variation in the P2 domain of the GII-4 norovirus VP1 protein reveals putative variant-specific epitopes. PLoS One. 2008;3(1):e1485.CrossRef Allen DJ, et al. Analysis of amino acid variation in the P2 domain of the GII-4 norovirus VP1 protein reveals putative variant-specific epitopes. PLoS One. 2008;3(1):e1485.CrossRef
11.
go back to reference Tam CC, et al. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut. 2012;61(1):69–77.CrossRef Tam CC, et al. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut. 2012;61(1):69–77.CrossRef
12.
go back to reference O'Brien SJ, et al. Methods for determining disease burden and calibrating national surveillance data in the United Kingdom: the second study of infectious intestinal disease in the community (IID2 study). BMC Med Res Methodol. 2010;10:39.CrossRef O'Brien SJ, et al. Methods for determining disease burden and calibrating national surveillance data in the United Kingdom: the second study of infectious intestinal disease in the community (IID2 study). BMC Med Res Methodol. 2010;10:39.CrossRef
13.
go back to reference Harris JP, Iturriza-Gomara M, O'Brien SJ. Re-assessing the total burden of norovirus circulating in the United Kingdom population. Vaccine. 2017;35(6):853–5.CrossRef Harris JP, Iturriza-Gomara M, O'Brien SJ. Re-assessing the total burden of norovirus circulating in the United Kingdom population. Vaccine. 2017;35(6):853–5.CrossRef
14.
go back to reference de Wit MA, et al. Sensor, a population-based cohort study on gastroenteritis in the Netherlands: incidence and etiology. Am J Epidemiol. 2001;154(7):666–74.CrossRef de Wit MA, et al. Sensor, a population-based cohort study on gastroenteritis in the Netherlands: incidence and etiology. Am J Epidemiol. 2001;154(7):666–74.CrossRef
15.
go back to reference O'Brien SJ, et al. Age-specific incidence rates for norovirus in the community and presenting to primary healthcare facilities in the United Kingdom. J Infect Dis. 2016;213(Suppl 1):S15–8.CrossRef O'Brien SJ, et al. Age-specific incidence rates for norovirus in the community and presenting to primary healthcare facilities in the United Kingdom. J Infect Dis. 2016;213(Suppl 1):S15–8.CrossRef
16.
go back to reference Tam CC, et al. The second study of infectious intestinal disease (IID2): increased rates of recurrent diarrhoea in individuals aged 65 years and above. BMC Public Health. 2013;13:739.CrossRef Tam CC, et al. The second study of infectious intestinal disease (IID2): increased rates of recurrent diarrhoea in individuals aged 65 years and above. BMC Public Health. 2013;13:739.CrossRef
17.
go back to reference Allen DJ, et al. Early detection of epidemic GII-4 norovirus strains in UK and Malawi: role of surveillance of sporadic acute gastroenteritis in anticipating global epidemics. PLoS One. 2016;11(4):e0146972.CrossRef Allen DJ, et al. Early detection of epidemic GII-4 norovirus strains in UK and Malawi: role of surveillance of sporadic acute gastroenteritis in anticipating global epidemics. PLoS One. 2016;11(4):e0146972.CrossRef
18.
go back to reference Lopman BA, et al. Clinical manifestation of norovirus gastroenteritis in health care settings. Clin Infect Dis. 2004;39(3):318–24.CrossRef Lopman BA, et al. Clinical manifestation of norovirus gastroenteritis in health care settings. Clin Infect Dis. 2004;39(3):318–24.CrossRef
19.
go back to reference Harris JP, et al. Deaths from norovirus among the elderly, England and Wales. Emerg Infect Dis. 2008;14(10):1546–52.CrossRef Harris JP, et al. Deaths from norovirus among the elderly, England and Wales. Emerg Infect Dis. 2008;14(10):1546–52.CrossRef
20.
go back to reference Gallimore CI, et al. Multiple norovirus genotypes characterised from an oyster-associated outbreak of gastroenteritis. Int J Food Microbiol. 2005;103(3):323–30.CrossRef Gallimore CI, et al. Multiple norovirus genotypes characterised from an oyster-associated outbreak of gastroenteritis. Int J Food Microbiol. 2005;103(3):323–30.CrossRef
21.
go back to reference Zheng DP, et al. Norovirus classification and proposed strain nomenclature. Virology. 2006;346(2):312–23.CrossRef Zheng DP, et al. Norovirus classification and proposed strain nomenclature. Virology. 2006;346(2):312–23.CrossRef
23.
go back to reference Phillips G, et al. Diagnosing norovirus-associated infectious intestinal disease using viral load. BMC Infect Dis. 2009;9(1):63.CrossRef Phillips G, et al. Diagnosing norovirus-associated infectious intestinal disease using viral load. BMC Infect Dis. 2009;9(1):63.CrossRef
26.
go back to reference Muenchhoff M, Goulder PJ. Sex differences in pediatric infectious diseases. J Infect Dis. 2014;209(Suppl 3):S120–6.CrossRef Muenchhoff M, Goulder PJ. Sex differences in pediatric infectious diseases. J Infect Dis. 2014;209(Suppl 3):S120–6.CrossRef
27.
go back to reference Siebenga JJ, et al. High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolution. J Infect Dis. 2008;198(7):994–1001.CrossRef Siebenga JJ, et al. High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolution. J Infect Dis. 2008;198(7):994–1001.CrossRef
28.
go back to reference Sukhrie FH, et al. Chronic shedders as reservoir for nosocomial transmission of norovirus. J Clin Microbiol. 2010;48(11):4303–5.CrossRef Sukhrie FH, et al. Chronic shedders as reservoir for nosocomial transmission of norovirus. J Clin Microbiol. 2010;48(11):4303–5.CrossRef
Metadata
Title
Norovirus strain types found within the second infectious intestinal diseases (IID2) study an analysis of norovirus circulating in the community
Authors
John P. Harris
Miren Iturriza-Gomara
David J. Allen
Susan Kelly
Sarah J. O’Brien
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-3706-z

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue